🧠 Mohammed (Mo) Abouelsoud's Linkedin Analytics

Mohammed "Mo" Abouelsoud is the CEO and Founder of U LLC, an international medical company pioneering neurotechnology solutions. With a background in computational neuroscience and applied physics from The Ohio State University, Mo leads a global team across six continents, connecting hospitals, patients, and regulatory officials. His expertise spans FDA dynamics, clinical trial development, capital allocation, electrical engineering, intellectual property development, neuroimaging data analysis, and software development. Under Mo's leadership, U has completed 2 clinical trials with 2 more currently in development across the USA, Pakistan, Brazil, and Democratic Republic of Congo, demonstrating up to 80% tremor reduction in Parkinson's disease. The company operates through specialized departments: Engineering (AI-EEG development, digital twin modeling, computer vision), Clinical (international trials and regulatory affairs), Marketing (Circle of Hope campaigns and engagement orders), and Scientific Research (fMRI analysis, molecular dynamics). Through U's "Circle of Hope" initiative, the company combines clinical excellence with humanitarian impact, establishing early access programs in developing nations while building toward commercial success in developed markets. As a passionate advocate for science education and entrepreneurship, Mo frequently engages in speaking events at schools from elementary to university level. His "From Neurons to Startups" presentations inspire students with real-world applications of neuroscience and entrepreneurship insights. Mo's journey from curious student to neuroscience CEO showcases his ability to bridge complex scientific concepts with innovative business strategies, making him a respected figure in both medical and entrepreneurial communities while advancing treatment for Parkinson's, Alzheimer's, and other neurological conditions.